BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

679 related articles for article (PubMed ID: 23538773)

  • 1. Rates and impact of hepatitis on human immunodeficiency virus infection in a large African cohort.
    Ladep NG; Agaba PA; Agbaji O; Muazu A; Ugoagwu P; Imade G; Cooke G; McCormack S; Taylor-Robinson SD; Idoko J; Kanki P
    World J Gastroenterol; 2013 Mar; 19(10):1602-10. PubMed ID: 23538773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological and virological response to haart in HIV-1 patients co-infected with hepatitis B and C viruses.
    Okwuraiwe AP; Audu RA; Salu OB; Onwuamah CK; Amoo OS; Ige FA; Meshack EH; Jamda PD; Odunukwe NN; Onwujekwe DI; Ezechi OC; Idigbe EO
    West Afr J Med; 2012; 31(2):124-8. PubMed ID: 23208483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Triple positivity of HBsAg, anti-HCV antibody, and HIV and their influence on CD4+ lymphocyte levels in the highly HIV infected population of Abeokuta, Nigeria.
    Ogwu-Richard SO; Ojo DA; Akingbade OA; Okonko IO
    Afr Health Sci; 2015 Sep; 15(3):719-27. PubMed ID: 26957958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program.
    Hoffmann CJ; Charalambous S; Martin DJ; Innes C; Churchyard GJ; Chaisson RE; Grant AD; Fielding KL; Thio CL
    Clin Infect Dis; 2008 Dec; 47(11):1479-85. PubMed ID: 18937580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High rates of active hepatitis B and C co-infections in HIV-1 infected Cameroonian adults initiating antiretroviral therapy.
    Laurent C; Bourgeois A; Mpoudi-Ngolé E; Kouanfack C; Ciaffi L; Nkoué N; Mougnutou R; Calmy A; Koulla-Shiro S; Ducos J; Delaporte E
    HIV Med; 2010 Jan; 11(1):85-9. PubMed ID: 19659944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of triple infection with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV) type-1 on CD4+ lymphocyte levels in the highly HIV infected population of North-Central Nigeria.
    Forbi JC; Gabadi S; Alabi R; Iperepolu HO; Pam CR; Entonu PE; Agwale SM
    Mem Inst Oswaldo Cruz; 2007 Jun; 102(4):535-7. PubMed ID: 17612776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B or hepatitis C coinfection in HIV-infected pregnant women in Europe.
    Landes M; Newell ML; Barlow P; Fiore S; Malyuta R; Martinelli P; Posokhova S; Savasi V; Semenenko I; Stelmah A; Tibaldi C; Thorne C
    HIV Med; 2008 Aug; 9(7):526-34. PubMed ID: 18554310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and impact of hepatitis B and C virus co-infections in antiretroviral treatment naïve patients with HIV infection at a major treatment center in Ghana.
    Sagoe KW; Agyei AA; Ziga F; Lartey M; Adiku TK; Seshi M; Arens MQ; Mingle JA
    J Med Virol; 2012 Jan; 84(1):6-10. PubMed ID: 22095533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients.
    Otegbayo JA; Taiwo BO; Akingbola TS; Odaibo GN; Adedapo KS; Penugonda S; Adewole IF; Olaleye DO; Murphy R; Kanki P
    Ann Hepatol; 2008; 7(2):152-6. PubMed ID: 18626434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of hepatitis B and C infection among the HIV-positive population in Abuja, Nigeria.
    Tremeau-Bravard A; Ogbukagu IC; Ticao CJ; Abubakar JJ
    Afr Health Sci; 2012 Sep; 12(3):312-7. PubMed ID: 23382745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria.
    Idoko J; Meloni S; Muazu M; Nimzing L; Badung B; Hawkins C; Sankalé JL; Ekong E; Murphy R; Kanki P; Thio CL
    Clin Infect Dis; 2009 Oct; 49(8):1268-73. PubMed ID: 19772386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective cohort study of immunologic and virologic outcomes in patients with HIV/AIDS and hepatitis virus co-infection in Jos, Nigeria.
    lsa SE; Gwamzhi LN; Akolo C; Giyan J
    Niger J Med; 2010; 19(3):279-85. PubMed ID: 20845631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigation of occult hepatitis B in HIV infected patients].
    Altınbaş A; Ergünay K; Calık Başaran N; Alp A; Turgut D; Hasçelik G; Uzun Ö; Unal S
    Mikrobiyol Bul; 2011 Apr; 45(2):353-8. PubMed ID: 21644079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presence of occult HBV, but near absence of active HBV and HCV infections in people infected with HIV in rural South Africa.
    Barth RE; Huijgen Q; Tempelman HA; Mudrikova T; Wensing AM; Hoepelman AI
    J Med Virol; 2011 Jun; 83(6):929-34. PubMed ID: 21503902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baseline CD4+ T lymphocyte cell counts, hepatitis B and C viruses seropositivity in adults with Human Immunodeficiency Virus infection at a tertiary hospital in Nigeria.
    Adekunle AE; Oladimeji AA; Temi AP; Adeseye AI; Akinyeye OA; Taiwo RH
    Pan Afr Med J; 2011; 9():6. PubMed ID: 22145054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of occult HBV infection in HIV/HCV co-infected patients: HBV-DNA detection in liver specimens and in serum samples.
    Fabris P; Biasin MR; Giordani MT; Berardo L; Menini V; Carlotto A; Miotti MG; Manfrin V; Baldo V; Nebbia G; Infantolino D
    Curr HIV Res; 2008 Mar; 6(2):173-9. PubMed ID: 18336266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy.
    Lincoln D; Petoumenos K; Dore GJ;
    HIV Med; 2003 Jul; 4(3):241-9. PubMed ID: 12859323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects.
    De Luca A; Bugarini R; Lepri AC; Puoti M; Girardi E; Antinori A; Poggio A; Pagano G; Tositti G; Cadeo G; Macor A; Toti M; D'Arminio Monforte A;
    Arch Intern Med; 2002 Oct; 162(18):2125-32. PubMed ID: 12374521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of loss of hepatitis B surface antigen in HIV-infected patients.
    Psevdos G; Kim JH; Suh JS; Sharp VL
    World J Gastroenterol; 2010 Mar; 16(9):1093-6. PubMed ID: 20205279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of hepatitis B and C virus in HIV-1 and HIV-2 infected Gambians.
    Jobarteh M; Malfroy M; Peterson I; Jeng A; Sarge-Njie R; Alabi A; Peterson K; Cotten M; Hall A; Rowland-Jones S; Whittle H; Tedder R; Jaye A; Mendy M
    Virol J; 2010 Sep; 7():230. PubMed ID: 20843322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.